PDCD1 and neoplasm: Programmed cell death 1 (PD-1, also known as CD279) is currently the most notable coinhibitory receptor to suppress T cell activation1 and finely tunes various types of immune responses, such as immunotolerance, antiviral immunity, tumor immunity, and antibody maturation2.